Early diagnosis and
complete treatment are the most important components of the malaria control program, which have a direct bearing on prevention of mortality and reduction in the morbidity, therefore, follow-up of
the patient treatment is an important aspect of monitoring disease in the
community. Aims: To assess treatment
compliance among confirmed malaria cases in Gandhinagar District and to
determine the proportion of cure rate with complete treatment as per the
national drug policy. Study Variables: Exploratory-rural and urban areas;
outcome-compliance, cure rate. Analysis:
Percentage, proportions. Results: Compliance among 192 subjects under
the study conducted in 2008 i.e. confirmed that malaria cases were 88%
even after the introduction of 14 day therapy for “Plasmodiumvivax” cases,
while 100% cure rate was observed on the follow-up till the 28th day among “P. vivax”
and “P. falciparum” cases which helped in reducing malaria incidence in the
rural area by 50% as compared to the preceding year of
the study. Conclusion: Follow-up of the treatment given to malaria patients has
enhanced compliance and cure rate, which in turn contributed towards interruption
of transmission. Therefore, a better cure rate through the administration of
effective antimalarial drugs as per the drug policy in combination with other
containment measures is the right strategy to keep morbidity and mortality due
to malaria under effective
References
[1]
“Annual Report,” National Vector Bone Disease Control Programme, Gujarat, 2009.
[2]
“Strategic Action Plan for Malaria Control in India, 2007-2012,” Directorate of National Vector Borne Disease Control Programme, Delhi.
[3]
R. C. Sharma and V. P. Sharma, “Epidemiological Implications of Population Migration—Part-II: Evidence of Chloroquine Resistant Plasmodium Falciparum Malaria in Kheda District of Gujarat,” Indian Journal of Malariology, Vol. 25, No. 2, 1988, pp. 117-118.
[4]
H. C. Srivastav, C. S. Pant, R. S. Yadav and P. B. Prajapati, “Malaria Transmission in Seasonal Migrants in South Gujarat: Obstacle to Malaria Control,” 2009.
[5]
H. C. Shrivastav, R. M. Bhatt, R. S. Yadav and V. P. Sharma, “Malaria Outbreak in Tribal Areas of Gujarat State-India,” South East Asian Journal of Tropical Medicine and Public Health, Vol. 31, No. 2, 2000, pp. 219-223.
[6]
H. C. Srivastav, R. S. Yadav, H. Joshi, N. Valecha, P. K. Mallik, S. K. Prajapati and A. P. Dash, “Therapeutic Responses of ‘Plasmodium vivax’ and ‘P. falciparum’ to Chloroquine in an Area of Western India Where P. vivax Predominates,” Annals of Tropical Medicine and Parasitology, Vol. 102, No. 6, 2008, pp. 471-480. http://dx.doi.org/10.1179/136485908X311759
[7]
“National Anti Malaria Drug Policy,” National Vector Borne Disease Control Programme, 2009.
Tijitra et al., “Efficacy of Chloroquine, Chloroquine plus Sulphadoxine-Pyrimethamine and Amodiaquine for Treatment of Vivax Malaria in Bangka Island, Indonesia: A Randomized Trial,” Medical Journal of Indonesia, 1996.
[10]
N. J. White, “The Role of Anti-Malarial Drugs in Eliminating Malaria,” Malaria Journal, Vol. 7, Suppl. 1, 2008, p. S8. http://dx.doi.org/10.1186/1475-2875-7-S1-S8
